Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$23.70 -0.26 (-1.09%)
2/9/2010 4:00 PM

ICON plc (ADR) (ICLR)

CAPS Rating:
*****

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ICLR

Add Stock to Watchlist

What the Community Thinks

Total Members

366 Outperforms
6 Underperforms
 

All-Stars

131 Outperforms
0 Underperforms
 

Wall Street

8 Outperforms
1 Underperforms
 

Members bullish on ICLR are also bullish on:

Members bearish on ICLR are also bearish on:

Ticker Tags

Growth (1902), Defensive (1457), Healthcare (711), Small Cap (1645), Contract Research Services (7), Ireland (9), Dublin (6), International Stock (684), Life Sciences Tools and Services (53)
Suggest a tag

ICON plc (ADR) At A Glance

Current Price: $23.70
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $23.96
Daily Range: $23.50 - $24.48
52-Week Range: $12.17 - $26.85
Volume: 529,709
Market Cap: $1.39B
P/E Ratio: 15.87
Compare Our Special Broker Offers!

Stock Trends

ICLR VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

ICON plc (ADR) (ICLR)

Avatar dollarpimp (68.82) Submitted: 1/18/08 7:38 PM

Discounted earnings valuation assuming 25% earnings growth over 10 years indicates this stock is selling at a substantial discount. Even assuming 20%, it's fairly priced. Just backed off a new high, buying on the dip. Healthcare sector will outperform.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 37 :   1 2 3 4 5 Next »

Recs

0

 (ICLR)

Avatar scoobamang (87.10) Submitted: 11/15/09 6:37 PM : Outperform Start Price: $22.65 ICLR Score: 7.50

Good fundamentals, steady growth in revenue and profit. It seems like they recently made some acquisitions and this is the reason it dropped down from $40, which I think it should return to relatively soon. Very little debt!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ICLR)

Avatar cfackler (98.59) Submitted: 10/22/09 9:59 AM : Outperform Start Price: $25.42 ICLR Score: -6.18

I love companies that serve other companies. Regardless of the success or failure of a drug trial, this company makes money.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ICLR)

Avatar TMFHelical (98.60) Submitted: 7/23/09 10:29 AM : Outperform Start Price: $21.82 ICLR Score: -2.09

Blanket pick on the CRO market under the assumption that it will return to growth in 2010. This just seems like the right time to make this call (we'll see).

TMFHelical

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ICLR)

Avatar DJWriter (90.71) Submitted: 7/07/09 1:57 PM : Outperform Start Price: $20.82 ICLR Score: -7.98

A history of growth. Strong financials. Should not be hurt too badly in a recession. Top management is invested.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ICLR)

Avatar ftblfntk56 (< 20) Submitted: 6/04/09 7:44 PM : Outperform Start Price: $20.12 ICLR Score: 4.37

I sold this stock today. I bought in at $15 last month and I am taking my 36% profit. I have it written down to get out before July as I feel the stock will have some poorer earnings reports. However, long term this stock is a sure fire winner, just not the next month. I'll re-evaluate it in August.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 37 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 9 of 9  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJPMorgan 84.76 07/16/09 Outperform NS $23.28+1.80%+15.83%-14.02
TrackDeutscheSec 89.68 05/13/09 Outperform NS $15.65+51.44%+20.73%+30.71
TrackJimCramer < 20 05/05/09 Underperform 3W $15.25+55.41%+19.63%-35.78
TrackBarclaysCap 94.50 01/08/09 Outperform NS $20.08+18.03%+20.87%-2.85
TrackUBS 87.99 01/11/08 Outperform NS $33.67-29.61%-20.63%-8.98
TrackWellsFargo 80.02 11/28/07 Outperform NS $28.76-17.61%-22.09%+4.48
TrackJefferies 82.08 10/15/07 Outperform NS $27.86-14.93%-28.11%+13.18
TrackEveillard 93.31 09/30/07 Outperform NS $25.51-7.11%-26.38%+19.26 Toggle the visibility of 60-Second Pitch and replies
TrackLehmanBros 85.06 10/30/06 Outperform NS $18.50+28.14%-17.30%+45.44

Results 1 - 9 of 9  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 812ms